Clinical Trial

Low Intensity Focused Ultrasound in ASD

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12 -> 2027-05 2026-05-23
minor Completion pushed: 2027-09 -> 2027-12 2026-05-23
Trial Details
NCT Number NCT07225322
Lead Sponsor Medical University of South Carolina
Collaborators: National Institute of General Medical Sciences (NIGMS), COBRE in Neurodevelopment and its Disorders (CNDD)
Conditions Autism Spectrum Disorder
Enrollment 20 participants
Start Date 2026-07
Primary Completion 2027-05 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-22